P-113d, an Antimicrobial Peptide Active against Pseudomonas aeruginosa, Retains Activity in the Presence of Sputum from Cystic Fibrosis Patients

Antimicrobial peptides are a source of novel agents that could be useful for treatment of the chronic lung infections that afflict cystic fibrosis (CF) patients. Efficacy depends on antimicrobial activity against the major pathogens of CF patients, Pseudomonas aeruginosa, Staphylococcus aureus, and...

Disgrifiad llawn

Manylion Llyfryddiaeth

Cyhoeddwyd yn:	Antimicrob Agents Chemother
Prif Awduron:	Sajjan, Umadevi S., Tran, Linh T., Sole, Nuria, Rovaldi, Christopher, Akiyama, Alan, Friden, Phillip M., Forstner, Janet F., Rothstein, David M.
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	American Society for Microbiology (ASM) 2001
Pynciau:	Susceptibility
Mynediad Ar-lein:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC90850/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11709321/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.45.12.3437-3444.2001
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!